---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-23-000861"
form_type: "8-K"
ticker: "ARCT"
cik: "0001768224"
company_name: "Arcturus Therapeutics Holdings Inc."
filed_at: "2023-06-16T23:59:59+00:00"
generated_at: "2026-06-13T23:00:18.297405+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Arcturus Therapeutics stockholders elect eight directors, approve say-on-pay and auditor ratification at annual meeting

## Summary
- All eight director nominees elected; Dr. Magda Marquet received lowest approval with 66.7% of votes for.
- Non-binding advisory say-on-pay resolution approved with 11,959,501 votes for (72.4%) vs 4,562,055 against.
- Ratification of Ernst & Young as auditor for FY2023 approved with 18,955,484 votes for, only 22,224 against.
- Quorum established with 18,987,002 shares represented (71.5% of outstanding 26,562,951 shares).

## SEC filing metadata
- accession: 0001193805-23-000861
- form_type: 8-K
- ticker: ARCT
- cik: 0001768224
- company_name: Arcturus Therapeutics Holdings Inc.
- filed_at: 2023-06-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768224/000119380523000861/0001193805-23-000861-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768224/000119380523000861/e618703_8k-arct.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-23-000861
- JSON: https://secwatch.observer/filing/0001193805-23-000861.json
- Plain text: https://secwatch.observer/filing/0001193805-23-000861.txt

## Key facts
- Shareholder Votes
  Arcturus Therapeutics Holdings Inc. shareholders approved To elect Dr. Peter Farrell, Joseph E. Payne, Andy Sassine, James Barlow, Dr. Edward W. Holmes, Dr. Magda Marquet, Dr. Jing L. Marantz and Dr. John H. Markels to the Board of Directors at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: (1) To elect Dr. Peter Farrell, Joseph E. Payne, Andy Sassine, James Barlow, Dr. Edward W. Holmes, Dr. Magda Marquet, Dr. Jing L. Marantz and Dr. John H. Markels to the Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380523000861/0001193805-23-000861-index.htm
- Shareholder Votes
  Arcturus Therapeutics Holdings Inc. shareholders approved To approve, on a non-binding advisory basis, the resolution approving named executive officer compensation (say-on-pay) at the 2023-06-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Approval, on a non-binding advisory basis, the resolution approving named executive officer compensation , referred to as "say-on-pay," as provided in Proposal Number 2 of the Proxy Statement: 11,959,501 4,562,055 15,403 2,450,043
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380523000861/0001193805-23-000861-index.htm
- Shareholder Votes
  Arcturus Therapeutics Holdings Inc. shareholders approved To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Approval of the ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023, as provided in Proposal Number 3 of the Proxy Statement: 18,955,484 22,224 9,294 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380523000861/0001193805-23-000861-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.